nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AR—hematologic cancer	0.238	1	CbGaD
Flutamide—CYP1B1—Procarbazine—hematologic cancer	0.0664	0.13	CbGbCtD
Flutamide—CYP1B1—Daunorubicin—hematologic cancer	0.0356	0.0696	CbGbCtD
Flutamide—CYP1B1—Dasatinib—hematologic cancer	0.0219	0.0428	CbGbCtD
Flutamide—CYP1B1—Mitoxantrone—hematologic cancer	0.0216	0.0423	CbGbCtD
Flutamide—CYP1A2—Anagrelide—hematologic cancer	0.0172	0.0336	CbGbCtD
Flutamide—CYP1A1—Methoxsalen—hematologic cancer	0.0172	0.0336	CbGbCtD
Flutamide—CYP1A1—Bortezomib—hematologic cancer	0.0163	0.0319	CbGbCtD
Flutamide—CYP1A1—Daunorubicin—hematologic cancer	0.0156	0.0306	CbGbCtD
Flutamide—CYP1A1—Thalidomide—hematologic cancer	0.0142	0.0278	CbGbCtD
Flutamide—CYP1A1—Dacarbazine—hematologic cancer	0.0122	0.0239	CbGbCtD
Flutamide—CYP1B1—Dexamethasone—hematologic cancer	0.0112	0.0219	CbGbCtD
Flutamide—CYP1A1—Dasatinib—hematologic cancer	0.00962	0.0188	CbGbCtD
Flutamide—CYP3A5—Daunorubicin—hematologic cancer	0.00938	0.0183	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—hematologic cancer	0.00931	0.0182	CbGbCtD
Flutamide—CYP1A2—Carmustine—hematologic cancer	0.00903	0.0176	CbGbCtD
Flutamide—CYP3A5—Thalidomide—hematologic cancer	0.00855	0.0167	CbGbCtD
Flutamide—CYP3A5—Teniposide—hematologic cancer	0.00815	0.0159	CbGbCtD
Flutamide—CYP2C19—Bortezomib—hematologic cancer	0.00791	0.0155	CbGbCtD
Flutamide—CYP1A2—Methoxsalen—hematologic cancer	0.00768	0.015	CbGbCtD
Flutamide—CYP3A5—Ifosfamide—hematologic cancer	0.00752	0.0147	CbGbCtD
Flutamide—CYP1A2—Bortezomib—hematologic cancer	0.0073	0.0143	CbGbCtD
Flutamide—CYP3A5—Imatinib—hematologic cancer	0.00719	0.014	CbGbCtD
Flutamide—CYP1A2—Daunorubicin—hematologic cancer	0.00698	0.0136	CbGbCtD
Flutamide—CYP2C19—Thalidomide—hematologic cancer	0.00689	0.0135	CbGbCtD
Flutamide—CYP1A2—Alitretinoin—hematologic cancer	0.00684	0.0134	CbGbCtD
Flutamide—CYP2C19—Teniposide—hematologic cancer	0.00658	0.0129	CbGbCtD
Flutamide—CYP1A2—Thalidomide—hematologic cancer	0.00636	0.0124	CbGbCtD
Flutamide—CYP3A4—Bexarotene—hematologic cancer	0.00624	0.0122	CbGbCtD
Flutamide—CYP2C19—Ifosfamide—hematologic cancer	0.00607	0.0119	CbGbCtD
Flutamide—CYP3A4—Lomustine—hematologic cancer	0.0058	0.0113	CbGbCtD
Flutamide—CYP3A4—Busulfan—hematologic cancer	0.0058	0.0113	CbGbCtD
Flutamide—CYP2C19—Imatinib—hematologic cancer	0.0058	0.0113	CbGbCtD
Flutamide—CYP3A5—Dasatinib—hematologic cancer	0.00577	0.0113	CbGbCtD
Flutamide—CYP1A2—Dacarbazine—hematologic cancer	0.00547	0.0107	CbGbCtD
Flutamide—CYP1A2—Imatinib—hematologic cancer	0.00535	0.0105	CbGbCtD
Flutamide—CYP3A4—Thiotepa—hematologic cancer	0.00517	0.0101	CbGbCtD
Flutamide—CYP1A1—Dexamethasone—hematologic cancer	0.00493	0.00963	CbGbCtD
Flutamide—CYP3A5—Irinotecan—hematologic cancer	0.00449	0.00877	CbGbCtD
Flutamide—CYP1A2—Dasatinib—hematologic cancer	0.0043	0.0084	CbGbCtD
Flutamide—CYP3A4—Methoxsalen—hematologic cancer	0.00402	0.00786	CbGbCtD
Flutamide—CYP3A5—Vincristine—hematologic cancer	0.00392	0.00767	CbGbCtD
Flutamide—CYP3A4—Bortezomib—hematologic cancer	0.00383	0.00748	CbGbCtD
Flutamide—CYP2C19—Prednisone—hematologic cancer	0.00382	0.00746	CbGbCtD
Flutamide—CYP3A4—Daunorubicin—hematologic cancer	0.00366	0.00715	CbGbCtD
Flutamide—CYP3A5—Etoposide—hematologic cancer	0.0036	0.00703	CbGbCtD
Flutamide—CYP3A4—Cytarabine—hematologic cancer	0.00323	0.00631	CbGbCtD
Flutamide—CYP3A4—Teniposide—hematologic cancer	0.00318	0.00621	CbGbCtD
Flutamide—CYP3A5—Dexamethasone—hematologic cancer	0.00296	0.00578	CbGbCtD
Flutamide—CYP3A4—Ifosfamide—hematologic cancer	0.00293	0.00573	CbGbCtD
Flutamide—CYP3A4—Imatinib—hematologic cancer	0.0028	0.00548	CbGbCtD
Flutamide—CYP1A2—Etoposide—hematologic cancer	0.00268	0.00523	CbGbCtD
Flutamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00264	0.00516	CbGbCtD
Flutamide—CYP3A4—Nilotinib—hematologic cancer	0.00255	0.00498	CbGbCtD
Flutamide—CYP3A4—Vinorelbine—hematologic cancer	0.00253	0.00494	CbGbCtD
Flutamide—CYP2C19—Dexamethasone—hematologic cancer	0.00238	0.00466	CbGbCtD
Flutamide—CYP3A4—Triamcinolone—hematologic cancer	0.00231	0.00451	CbGbCtD
Flutamide—CYP3A4—Dasatinib—hematologic cancer	0.00225	0.0044	CbGbCtD
Flutamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00222	0.00435	CbGbCtD
Flutamide—CYP3A4—Betamethasone—hematologic cancer	0.00198	0.00387	CbGbCtD
Flutamide—CYP3A4—Prednisolone—hematologic cancer	0.00196	0.00382	CbGbCtD
Flutamide—CYP3A4—Prednisone—hematologic cancer	0.00185	0.00361	CbGbCtD
Flutamide—CYP3A4—Irinotecan—hematologic cancer	0.00175	0.00342	CbGbCtD
Flutamide—CYP3A4—Vinblastine—hematologic cancer	0.00156	0.00304	CbGbCtD
Flutamide—CYP3A4—Vincristine—hematologic cancer	0.00153	0.00299	CbGbCtD
Flutamide—CYP3A4—Etoposide—hematologic cancer	0.0014	0.00274	CbGbCtD
Flutamide—CYP3A4—Dexamethasone—hematologic cancer	0.00115	0.00225	CbGbCtD
Flutamide—Nilutamide—AR—hematologic cancer	0.00113	1	CrCbGaD
Flutamide—AHR—blood—hematologic cancer	0.00101	0.0622	CbGeAlD
Flutamide—AHR—bone marrow—hematologic cancer	0.000974	0.0601	CbGeAlD
Flutamide—CYP3A4—Doxorubicin—hematologic cancer	0.000956	0.00187	CbGbCtD
Flutamide—AHR—lung—hematologic cancer	0.000883	0.0545	CbGeAlD
Flutamide—AHR—testis—hematologic cancer	0.000833	0.0514	CbGeAlD
Flutamide—CYP1B1—hematopoietic system—hematologic cancer	0.000792	0.0489	CbGeAlD
Flutamide—AR—hematopoietic system—hematologic cancer	0.00075	0.0463	CbGeAlD
Flutamide—CYP2C19—hematopoietic system—hematologic cancer	0.000695	0.0429	CbGeAlD
Flutamide—AHR—lymph node—hematologic cancer	0.000604	0.0373	CbGeAlD
Flutamide—CYP1B1—gonad—hematologic cancer	0.000602	0.0372	CbGeAlD
Flutamide—AR—gonad—hematologic cancer	0.00057	0.0352	CbGeAlD
Flutamide—CYP1A2—hematopoietic system—hematologic cancer	0.000567	0.035	CbGeAlD
Flutamide—CYP1A1—hematopoietic system—hematologic cancer	0.00056	0.0345	CbGeAlD
Flutamide—CYP3A5—hematopoietic system—hematologic cancer	0.000547	0.0338	CbGeAlD
Flutamide—CYP1B1—blood—hematologic cancer	0.000524	0.0324	CbGeAlD
Flutamide—AR—blood—hematologic cancer	0.000497	0.0307	CbGeAlD
Flutamide—CYP2C19—blood—hematologic cancer	0.00046	0.0284	CbGeAlD
Flutamide—CYP1B1—lung—hematologic cancer	0.00046	0.0284	CbGeAlD
Flutamide—AR—lung—hematologic cancer	0.000435	0.0269	CbGeAlD
Flutamide—CYP1B1—testis—hematologic cancer	0.000434	0.0268	CbGeAlD
Flutamide—AR—testis—hematologic cancer	0.000411	0.0254	CbGeAlD
Flutamide—CYP3A4—hematopoietic system—hematologic cancer	0.000411	0.0253	CbGeAlD
Flutamide—CYP1A2—blood—hematologic cancer	0.000376	0.0232	CbGeAlD
Flutamide—CYP1A1—blood—hematologic cancer	0.000371	0.0229	CbGeAlD
Flutamide—CYP3A5—blood—hematologic cancer	0.000363	0.0224	CbGeAlD
Flutamide—CYP1A2—lung—hematologic cancer	0.00033	0.0203	CbGeAlD
Flutamide—CYP1A1—lung—hematologic cancer	0.000325	0.0201	CbGeAlD
Flutamide—CYP3A5—lung—hematologic cancer	0.000318	0.0196	CbGeAlD
Flutamide—CYP1B1—lymph node—hematologic cancer	0.000314	0.0194	CbGeAlD
Flutamide—AR—lymph node—hematologic cancer	0.000298	0.0184	CbGeAlD
Flutamide—CYP3A4—blood—hematologic cancer	0.000272	0.0168	CbGeAlD
Flutamide—CYP1A1—lymph node—hematologic cancer	0.000222	0.0137	CbGeAlD
Flutamide—Decreased appetite—Etoposide—hematologic cancer	3.72e-05	0.000236	CcSEcCtD
Flutamide—Diarrhoea—Ifosfamide—hematologic cancer	3.71e-05	0.000235	CcSEcCtD
Flutamide—Nausea—Vinorelbine—hematologic cancer	3.71e-05	0.000235	CcSEcCtD
Flutamide—Asthenia—Mitoxantrone—hematologic cancer	3.69e-05	0.000234	CcSEcCtD
Flutamide—Asthenia—Irinotecan—hematologic cancer	3.69e-05	0.000234	CcSEcCtD
Flutamide—Fatigue—Etoposide—hematologic cancer	3.69e-05	0.000234	CcSEcCtD
Flutamide—Jaundice—Epirubicin—hematologic cancer	3.67e-05	0.000232	CcSEcCtD
Flutamide—Vomiting—Thalidomide—hematologic cancer	3.66e-05	0.000232	CcSEcCtD
Flutamide—Anxiety—Dexamethasone—hematologic cancer	3.66e-05	0.000232	CcSEcCtD
Flutamide—Anxiety—Betamethasone—hematologic cancer	3.66e-05	0.000232	CcSEcCtD
Flutamide—Dizziness—Carmustine—hematologic cancer	3.66e-05	0.000232	CcSEcCtD
Flutamide—Constipation—Etoposide—hematologic cancer	3.66e-05	0.000232	CcSEcCtD
Flutamide—Rash—Thalidomide—hematologic cancer	3.63e-05	0.00023	CcSEcCtD
Flutamide—Discomfort—Dexamethasone—hematologic cancer	3.63e-05	0.00023	CcSEcCtD
Flutamide—Discomfort—Betamethasone—hematologic cancer	3.63e-05	0.00023	CcSEcCtD
Flutamide—Dermatitis—Thalidomide—hematologic cancer	3.63e-05	0.00023	CcSEcCtD
Flutamide—Dizziness—Alitretinoin—hematologic cancer	3.63e-05	0.00023	CcSEcCtD
Flutamide—Diarrhoea—Vincristine—hematologic cancer	3.62e-05	0.000229	CcSEcCtD
Flutamide—Headache—Thalidomide—hematologic cancer	3.61e-05	0.000229	CcSEcCtD
Flutamide—Hepatitis—Methotrexate—hematologic cancer	3.61e-05	0.000228	CcSEcCtD
Flutamide—Asthenia—Gemcitabine—hematologic cancer	3.6e-05	0.000228	CcSEcCtD
Flutamide—Haematuria—Epirubicin—hematologic cancer	3.59e-05	0.000227	CcSEcCtD
Flutamide—Dizziness—Ifosfamide—hematologic cancer	3.58e-05	0.000227	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—hematologic cancer	3.56e-05	0.000226	CcSEcCtD
Flutamide—Pruritus—Gemcitabine—hematologic cancer	3.55e-05	0.000224	CcSEcCtD
Flutamide—Nausea—Thiotepa—hematologic cancer	3.54e-05	0.000224	CcSEcCtD
Flutamide—Feeling abnormal—Etoposide—hematologic cancer	3.53e-05	0.000223	CcSEcCtD
Flutamide—Oedema—Betamethasone—hematologic cancer	3.52e-05	0.000223	CcSEcCtD
Flutamide—Oedema—Dexamethasone—hematologic cancer	3.52e-05	0.000223	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—hematologic cancer	3.52e-05	0.000223	CcSEcCtD
Flutamide—Diarrhoea—Mitoxantrone—hematologic cancer	3.52e-05	0.000223	CcSEcCtD
Flutamide—Diarrhoea—Irinotecan—hematologic cancer	3.52e-05	0.000223	CcSEcCtD
Flutamide—Vomiting—Carmustine—hematologic cancer	3.52e-05	0.000223	CcSEcCtD
Flutamide—Insomnia—Triamcinolone—hematologic cancer	3.51e-05	0.000222	CcSEcCtD
Flutamide—Dizziness—Vincristine—hematologic cancer	3.49e-05	0.000221	CcSEcCtD
Flutamide—Rash—Carmustine—hematologic cancer	3.49e-05	0.000221	CcSEcCtD
Flutamide—Ill-defined disorder—Prednisone—hematologic cancer	3.49e-05	0.000221	CcSEcCtD
Flutamide—Dermatitis—Carmustine—hematologic cancer	3.49e-05	0.000221	CcSEcCtD
Flutamide—Vomiting—Alitretinoin—hematologic cancer	3.49e-05	0.000221	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—hematologic cancer	3.48e-05	0.00022	CcSEcCtD
Flutamide—Feeling abnormal—Prednisolone—hematologic cancer	3.48e-05	0.00022	CcSEcCtD
Flutamide—Anaemia—Prednisone—hematologic cancer	3.47e-05	0.00022	CcSEcCtD
Flutamide—Headache—Carmustine—hematologic cancer	3.47e-05	0.000219	CcSEcCtD
Flutamide—Rash—Alitretinoin—hematologic cancer	3.46e-05	0.000219	CcSEcCtD
Flutamide—Dermatitis—Alitretinoin—hematologic cancer	3.45e-05	0.000219	CcSEcCtD
Flutamide—Thrombocytopenia—Dexamethasone—hematologic cancer	3.45e-05	0.000218	CcSEcCtD
Flutamide—Thrombocytopenia—Betamethasone—hematologic cancer	3.45e-05	0.000218	CcSEcCtD
Flutamide—Vomiting—Ifosfamide—hematologic cancer	3.45e-05	0.000218	CcSEcCtD
Flutamide—Headache—Alitretinoin—hematologic cancer	3.44e-05	0.000217	CcSEcCtD
Flutamide—Diarrhoea—Gemcitabine—hematologic cancer	3.43e-05	0.000217	CcSEcCtD
Flutamide—Nausea—Thalidomide—hematologic cancer	3.42e-05	0.000217	CcSEcCtD
Flutamide—Rash—Ifosfamide—hematologic cancer	3.42e-05	0.000216	CcSEcCtD
Flutamide—Dermatitis—Ifosfamide—hematologic cancer	3.41e-05	0.000216	CcSEcCtD
Flutamide—Dizziness—Irinotecan—hematologic cancer	3.4e-05	0.000215	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—hematologic cancer	3.39e-05	0.000215	CcSEcCtD
Flutamide—Malaise—Prednisone—hematologic cancer	3.39e-05	0.000215	CcSEcCtD
Flutamide—Hepatitis—Epirubicin—hematologic cancer	3.38e-05	0.000214	CcSEcCtD
Flutamide—Vomiting—Vincristine—hematologic cancer	3.36e-05	0.000213	CcSEcCtD
Flutamide—Anorexia—Dexamethasone—hematologic cancer	3.36e-05	0.000213	CcSEcCtD
Flutamide—Anorexia—Betamethasone—hematologic cancer	3.36e-05	0.000213	CcSEcCtD
Flutamide—Asthenia—Cisplatin—hematologic cancer	3.35e-05	0.000212	CcSEcCtD
Flutamide—Fatigue—Triamcinolone—hematologic cancer	3.35e-05	0.000212	CcSEcCtD
Flutamide—Rash—Vincristine—hematologic cancer	3.33e-05	0.000211	CcSEcCtD
Flutamide—Dermatitis—Vincristine—hematologic cancer	3.33e-05	0.000211	CcSEcCtD
Flutamide—Oedema peripheral—Epirubicin—hematologic cancer	3.33e-05	0.000211	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—hematologic cancer	3.32e-05	0.00021	CcSEcCtD
Flutamide—Headache—Vincristine—hematologic cancer	3.31e-05	0.00021	CcSEcCtD
Flutamide—Nausea—Carmustine—hematologic cancer	3.29e-05	0.000208	CcSEcCtD
Flutamide—Vomiting—Mitoxantrone—hematologic cancer	3.27e-05	0.000207	CcSEcCtD
Flutamide—Vomiting—Irinotecan—hematologic cancer	3.27e-05	0.000207	CcSEcCtD
Flutamide—Nausea—Alitretinoin—hematologic cancer	3.26e-05	0.000206	CcSEcCtD
Flutamide—Hypertension—Prednisone—hematologic cancer	3.25e-05	0.000205	CcSEcCtD
Flutamide—Rash—Irinotecan—hematologic cancer	3.24e-05	0.000205	CcSEcCtD
Flutamide—Rash—Mitoxantrone—hematologic cancer	3.24e-05	0.000205	CcSEcCtD
Flutamide—Dermatitis—Mitoxantrone—hematologic cancer	3.24e-05	0.000205	CcSEcCtD
Flutamide—Dermatitis—Irinotecan—hematologic cancer	3.24e-05	0.000205	CcSEcCtD
Flutamide—Headache—Irinotecan—hematologic cancer	3.22e-05	0.000204	CcSEcCtD
Flutamide—Headache—Mitoxantrone—hematologic cancer	3.22e-05	0.000204	CcSEcCtD
Flutamide—Nausea—Ifosfamide—hematologic cancer	3.22e-05	0.000204	CcSEcCtD
Flutamide—Feeling abnormal—Triamcinolone—hematologic cancer	3.2e-05	0.000203	CcSEcCtD
Flutamide—Diarrhoea—Cisplatin—hematologic cancer	3.2e-05	0.000202	CcSEcCtD
Flutamide—Anxiety—Prednisone—hematologic cancer	3.19e-05	0.000202	CcSEcCtD
Flutamide—Vomiting—Gemcitabine—hematologic cancer	3.19e-05	0.000202	CcSEcCtD
Flutamide—Insomnia—Dexamethasone—hematologic cancer	3.19e-05	0.000202	CcSEcCtD
Flutamide—Insomnia—Betamethasone—hematologic cancer	3.19e-05	0.000202	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.18e-05	0.000201	CcSEcCtD
Flutamide—Discomfort—Prednisone—hematologic cancer	3.16e-05	0.0002	CcSEcCtD
Flutamide—Rash—Gemcitabine—hematologic cancer	3.16e-05	0.0002	CcSEcCtD
Flutamide—Dermatitis—Gemcitabine—hematologic cancer	3.16e-05	0.0002	CcSEcCtD
Flutamide—Erythema—Methotrexate—hematologic cancer	3.14e-05	0.000199	CcSEcCtD
Flutamide—Headache—Gemcitabine—hematologic cancer	3.14e-05	0.000199	CcSEcCtD
Flutamide—Nausea—Vincristine—hematologic cancer	3.14e-05	0.000199	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—hematologic cancer	3.13e-05	0.000198	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—hematologic cancer	3.08e-05	0.000195	CcSEcCtD
Flutamide—Asthenia—Etoposide—hematologic cancer	3.07e-05	0.000194	CcSEcCtD
Flutamide—Oedema—Prednisone—hematologic cancer	3.07e-05	0.000194	CcSEcCtD
Flutamide—Decreased appetite—Dexamethasone—hematologic cancer	3.06e-05	0.000194	CcSEcCtD
Flutamide—Decreased appetite—Betamethasone—hematologic cancer	3.06e-05	0.000194	CcSEcCtD
Flutamide—Nausea—Mitoxantrone—hematologic cancer	3.06e-05	0.000193	CcSEcCtD
Flutamide—Nausea—Irinotecan—hematologic cancer	3.06e-05	0.000193	CcSEcCtD
Flutamide—Fatigue—Betamethasone—hematologic cancer	3.04e-05	0.000192	CcSEcCtD
Flutamide—Fatigue—Dexamethasone—hematologic cancer	3.04e-05	0.000192	CcSEcCtD
Flutamide—Pruritus—Etoposide—hematologic cancer	3.03e-05	0.000192	CcSEcCtD
Flutamide—Skin disorder—Prednisone—hematologic cancer	2.98e-05	0.000189	CcSEcCtD
Flutamide—Nausea—Gemcitabine—hematologic cancer	2.98e-05	0.000188	CcSEcCtD
Flutamide—Vomiting—Cisplatin—hematologic cancer	2.97e-05	0.000188	CcSEcCtD
Flutamide—Rash—Cisplatin—hematologic cancer	2.95e-05	0.000186	CcSEcCtD
Flutamide—Dermatitis—Cisplatin—hematologic cancer	2.94e-05	0.000186	CcSEcCtD
Flutamide—Erythema—Epirubicin—hematologic cancer	2.94e-05	0.000186	CcSEcCtD
Flutamide—Diarrhoea—Etoposide—hematologic cancer	2.93e-05	0.000185	CcSEcCtD
Flutamide—Anorexia—Prednisone—hematologic cancer	2.92e-05	0.000185	CcSEcCtD
Flutamide—Ill-defined disorder—Methotrexate—hematologic cancer	2.92e-05	0.000184	CcSEcCtD
Flutamide—Anaemia—Methotrexate—hematologic cancer	2.9e-05	0.000184	CcSEcCtD
Flutamide—Feeling abnormal—Dexamethasone—hematologic cancer	2.9e-05	0.000184	CcSEcCtD
Flutamide—Feeling abnormal—Betamethasone—hematologic cancer	2.9e-05	0.000184	CcSEcCtD
Flutamide—Tension—Epirubicin—hematologic cancer	2.89e-05	0.000183	CcSEcCtD
Flutamide—Nervousness—Epirubicin—hematologic cancer	2.86e-05	0.000181	CcSEcCtD
Flutamide—Malaise—Methotrexate—hematologic cancer	2.83e-05	0.000179	CcSEcCtD
Flutamide—Dizziness—Etoposide—hematologic cancer	2.83e-05	0.000179	CcSEcCtD
Flutamide—Leukopenia—Methotrexate—hematologic cancer	2.81e-05	0.000178	CcSEcCtD
Flutamide—Dizziness—Prednisolone—hematologic cancer	2.79e-05	0.000177	CcSEcCtD
Flutamide—Asthenia—Triamcinolone—hematologic cancer	2.79e-05	0.000176	CcSEcCtD
Flutamide—Nausea—Cisplatin—hematologic cancer	2.78e-05	0.000176	CcSEcCtD
Flutamide—Insomnia—Prednisone—hematologic cancer	2.78e-05	0.000176	CcSEcCtD
Flutamide—Pruritus—Triamcinolone—hematologic cancer	2.75e-05	0.000174	CcSEcCtD
Flutamide—Ill-defined disorder—Epirubicin—hematologic cancer	2.73e-05	0.000173	CcSEcCtD
Flutamide—Vomiting—Etoposide—hematologic cancer	2.72e-05	0.000172	CcSEcCtD
Flutamide—Erythema—Doxorubicin—hematologic cancer	2.72e-05	0.000172	CcSEcCtD
Flutamide—Anaemia—Epirubicin—hematologic cancer	2.72e-05	0.000172	CcSEcCtD
Flutamide—Rash—Etoposide—hematologic cancer	2.7e-05	0.000171	CcSEcCtD
Flutamide—Dermatitis—Etoposide—hematologic cancer	2.7e-05	0.000171	CcSEcCtD
Flutamide—Headache—Etoposide—hematologic cancer	2.68e-05	0.00017	CcSEcCtD
Flutamide—Tension—Doxorubicin—hematologic cancer	2.67e-05	0.000169	CcSEcCtD
Flutamide—Decreased appetite—Prednisone—hematologic cancer	2.67e-05	0.000169	CcSEcCtD
Flutamide—Rash—Prednisolone—hematologic cancer	2.66e-05	0.000168	CcSEcCtD
Flutamide—Dermatitis—Prednisolone—hematologic cancer	2.66e-05	0.000168	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.66e-05	0.000168	CcSEcCtD
Flutamide—Malaise—Epirubicin—hematologic cancer	2.65e-05	0.000168	CcSEcCtD
Flutamide—Fatigue—Prednisone—hematologic cancer	2.65e-05	0.000167	CcSEcCtD
Flutamide—Headache—Prednisolone—hematologic cancer	2.65e-05	0.000167	CcSEcCtD
Flutamide—Discomfort—Methotrexate—hematologic cancer	2.64e-05	0.000167	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—hematologic cancer	2.64e-05	0.000167	CcSEcCtD
Flutamide—Leukopenia—Epirubicin—hematologic cancer	2.63e-05	0.000167	CcSEcCtD
Flutamide—Constipation—Prednisone—hematologic cancer	2.62e-05	0.000166	CcSEcCtD
Flutamide—Confusional state—Methotrexate—hematologic cancer	2.59e-05	0.000164	CcSEcCtD
Flutamide—Dizziness—Triamcinolone—hematologic cancer	2.57e-05	0.000163	CcSEcCtD
Flutamide—Nausea—Etoposide—hematologic cancer	2.54e-05	0.000161	CcSEcCtD
Flutamide—Hypertension—Epirubicin—hematologic cancer	2.54e-05	0.000161	CcSEcCtD
Flutamide—Feeling abnormal—Prednisone—hematologic cancer	2.53e-05	0.00016	CcSEcCtD
Flutamide—Asthenia—Betamethasone—hematologic cancer	2.53e-05	0.00016	CcSEcCtD
Flutamide—Asthenia—Dexamethasone—hematologic cancer	2.53e-05	0.00016	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—hematologic cancer	2.52e-05	0.00016	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—hematologic cancer	2.51e-05	0.000159	CcSEcCtD
Flutamide—Thrombocytopenia—Methotrexate—hematologic cancer	2.51e-05	0.000159	CcSEcCtD
Flutamide—Nausea—Prednisolone—hematologic cancer	2.51e-05	0.000159	CcSEcCtD
Flutamide—Anxiety—Epirubicin—hematologic cancer	2.49e-05	0.000158	CcSEcCtD
Flutamide—Pruritus—Dexamethasone—hematologic cancer	2.49e-05	0.000158	CcSEcCtD
Flutamide—Pruritus—Betamethasone—hematologic cancer	2.49e-05	0.000158	CcSEcCtD
Flutamide—Skin disorder—Methotrexate—hematologic cancer	2.49e-05	0.000158	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.49e-05	0.000157	CcSEcCtD
Flutamide—Discomfort—Epirubicin—hematologic cancer	2.47e-05	0.000157	CcSEcCtD
Flutamide—Vomiting—Triamcinolone—hematologic cancer	2.47e-05	0.000156	CcSEcCtD
Flutamide—Malaise—Doxorubicin—hematologic cancer	2.45e-05	0.000155	CcSEcCtD
Flutamide—Rash—Triamcinolone—hematologic cancer	2.45e-05	0.000155	CcSEcCtD
Flutamide—Dermatitis—Triamcinolone—hematologic cancer	2.45e-05	0.000155	CcSEcCtD
Flutamide—Anorexia—Methotrexate—hematologic cancer	2.44e-05	0.000155	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—hematologic cancer	2.44e-05	0.000154	CcSEcCtD
Flutamide—Headache—Triamcinolone—hematologic cancer	2.43e-05	0.000154	CcSEcCtD
Flutamide—Confusional state—Epirubicin—hematologic cancer	2.42e-05	0.000153	CcSEcCtD
Flutamide—Diarrhoea—Dexamethasone—hematologic cancer	2.41e-05	0.000153	CcSEcCtD
Flutamide—Diarrhoea—Betamethasone—hematologic cancer	2.41e-05	0.000153	CcSEcCtD
Flutamide—Oedema—Epirubicin—hematologic cancer	2.4e-05	0.000152	CcSEcCtD
Flutamide—Thrombocytopenia—Epirubicin—hematologic cancer	2.35e-05	0.000149	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—hematologic cancer	2.35e-05	0.000149	CcSEcCtD
Flutamide—Skin disorder—Epirubicin—hematologic cancer	2.33e-05	0.000148	CcSEcCtD
Flutamide—Dizziness—Dexamethasone—hematologic cancer	2.33e-05	0.000147	CcSEcCtD
Flutamide—Dizziness—Betamethasone—hematologic cancer	2.33e-05	0.000147	CcSEcCtD
Flutamide—Insomnia—Methotrexate—hematologic cancer	2.32e-05	0.000147	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—hematologic cancer	2.31e-05	0.000146	CcSEcCtD
Flutamide—Nausea—Triamcinolone—hematologic cancer	2.31e-05	0.000146	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.3e-05	0.000146	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—hematologic cancer	2.29e-05	0.000145	CcSEcCtD
Flutamide—Anorexia—Epirubicin—hematologic cancer	2.29e-05	0.000145	CcSEcCtD
Flutamide—Somnolence—Methotrexate—hematologic cancer	2.28e-05	0.000144	CcSEcCtD
Flutamide—Vomiting—Dexamethasone—hematologic cancer	2.24e-05	0.000142	CcSEcCtD
Flutamide—Vomiting—Betamethasone—hematologic cancer	2.24e-05	0.000142	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—hematologic cancer	2.24e-05	0.000142	CcSEcCtD
Flutamide—Decreased appetite—Methotrexate—hematologic cancer	2.23e-05	0.000141	CcSEcCtD
Flutamide—Rash—Betamethasone—hematologic cancer	2.22e-05	0.000141	CcSEcCtD
Flutamide—Rash—Dexamethasone—hematologic cancer	2.22e-05	0.000141	CcSEcCtD
Flutamide—Oedema—Doxorubicin—hematologic cancer	2.22e-05	0.000141	CcSEcCtD
Flutamide—Dermatitis—Betamethasone—hematologic cancer	2.22e-05	0.00014	CcSEcCtD
Flutamide—Dermatitis—Dexamethasone—hematologic cancer	2.22e-05	0.00014	CcSEcCtD
Flutamide—Fatigue—Methotrexate—hematologic cancer	2.21e-05	0.00014	CcSEcCtD
Flutamide—Headache—Betamethasone—hematologic cancer	2.21e-05	0.00014	CcSEcCtD
Flutamide—Headache—Dexamethasone—hematologic cancer	2.21e-05	0.00014	CcSEcCtD
Flutamide—Asthenia—Prednisone—hematologic cancer	2.2e-05	0.000139	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—hematologic cancer	2.17e-05	0.000138	CcSEcCtD
Flutamide—Pruritus—Prednisone—hematologic cancer	2.17e-05	0.000137	CcSEcCtD
Flutamide—Insomnia—Epirubicin—hematologic cancer	2.17e-05	0.000137	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—hematologic cancer	2.16e-05	0.000136	CcSEcCtD
Flutamide—Somnolence—Epirubicin—hematologic cancer	2.13e-05	0.000135	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—hematologic cancer	2.12e-05	0.000134	CcSEcCtD
Flutamide—Feeling abnormal—Methotrexate—hematologic cancer	2.11e-05	0.000134	CcSEcCtD
Flutamide—Diarrhoea—Prednisone—hematologic cancer	2.1e-05	0.000133	CcSEcCtD
Flutamide—Nausea—Betamethasone—hematologic cancer	2.09e-05	0.000132	CcSEcCtD
Flutamide—Nausea—Dexamethasone—hematologic cancer	2.09e-05	0.000132	CcSEcCtD
Flutamide—Decreased appetite—Epirubicin—hematologic cancer	2.09e-05	0.000132	CcSEcCtD
Flutamide—Fatigue—Epirubicin—hematologic cancer	2.07e-05	0.000131	CcSEcCtD
Flutamide—Constipation—Epirubicin—hematologic cancer	2.05e-05	0.00013	CcSEcCtD
Flutamide—Dizziness—Prednisone—hematologic cancer	2.03e-05	0.000128	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—hematologic cancer	2.01e-05	0.000127	CcSEcCtD
Flutamide—Feeling abnormal—Epirubicin—hematologic cancer	1.98e-05	0.000125	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—hematologic cancer	1.97e-05	0.000125	CcSEcCtD
Flutamide—Vomiting—Prednisone—hematologic cancer	1.95e-05	0.000123	CcSEcCtD
Flutamide—Rash—Prednisone—hematologic cancer	1.93e-05	0.000122	CcSEcCtD
Flutamide—Dermatitis—Prednisone—hematologic cancer	1.93e-05	0.000122	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—hematologic cancer	1.93e-05	0.000122	CcSEcCtD
Flutamide—Headache—Prednisone—hematologic cancer	1.92e-05	0.000122	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—hematologic cancer	1.91e-05	0.000121	CcSEcCtD
Flutamide—Constipation—Doxorubicin—hematologic cancer	1.9e-05	0.00012	CcSEcCtD
Flutamide—Asthenia—Methotrexate—hematologic cancer	1.84e-05	0.000116	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—hematologic cancer	1.83e-05	0.000116	CcSEcCtD
Flutamide—Nausea—Prednisone—hematologic cancer	1.82e-05	0.000115	CcSEcCtD
Flutamide—Pruritus—Methotrexate—hematologic cancer	1.81e-05	0.000115	CcSEcCtD
Flutamide—Diarrhoea—Methotrexate—hematologic cancer	1.75e-05	0.000111	CcSEcCtD
Flutamide—Asthenia—Epirubicin—hematologic cancer	1.72e-05	0.000109	CcSEcCtD
Flutamide—Pruritus—Epirubicin—hematologic cancer	1.7e-05	0.000107	CcSEcCtD
Flutamide—Dizziness—Methotrexate—hematologic cancer	1.7e-05	0.000107	CcSEcCtD
Flutamide—Diarrhoea—Epirubicin—hematologic cancer	1.64e-05	0.000104	CcSEcCtD
Flutamide—Vomiting—Methotrexate—hematologic cancer	1.63e-05	0.000103	CcSEcCtD
Flutamide—Rash—Methotrexate—hematologic cancer	1.62e-05	0.000102	CcSEcCtD
Flutamide—Dermatitis—Methotrexate—hematologic cancer	1.62e-05	0.000102	CcSEcCtD
Flutamide—Headache—Methotrexate—hematologic cancer	1.61e-05	0.000102	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—hematologic cancer	1.59e-05	0.000101	CcSEcCtD
Flutamide—Dizziness—Epirubicin—hematologic cancer	1.59e-05	0.0001	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—hematologic cancer	1.57e-05	9.94e-05	CcSEcCtD
Flutamide—Vomiting—Epirubicin—hematologic cancer	1.53e-05	9.66e-05	CcSEcCtD
Flutamide—Nausea—Methotrexate—hematologic cancer	1.52e-05	9.64e-05	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—hematologic cancer	1.52e-05	9.61e-05	CcSEcCtD
Flutamide—Rash—Epirubicin—hematologic cancer	1.51e-05	9.58e-05	CcSEcCtD
Flutamide—Dermatitis—Epirubicin—hematologic cancer	1.51e-05	9.57e-05	CcSEcCtD
Flutamide—Headache—Epirubicin—hematologic cancer	1.5e-05	9.51e-05	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—hematologic cancer	1.47e-05	9.29e-05	CcSEcCtD
Flutamide—Nausea—Epirubicin—hematologic cancer	1.43e-05	9.02e-05	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—hematologic cancer	1.41e-05	8.93e-05	CcSEcCtD
Flutamide—Rash—Doxorubicin—hematologic cancer	1.4e-05	8.86e-05	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—hematologic cancer	1.4e-05	8.85e-05	CcSEcCtD
Flutamide—Headache—Doxorubicin—hematologic cancer	1.39e-05	8.8e-05	CcSEcCtD
Flutamide—Nausea—Doxorubicin—hematologic cancer	1.32e-05	8.35e-05	CcSEcCtD
Flutamide—CYP3A5—Metabolism—ALOX5—hematologic cancer	6.45e-06	8.62e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—UGT1A1—hematologic cancer	6.42e-06	8.59e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC22A1—hematologic cancer	6.25e-06	8.36e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CRABP1—hematologic cancer	6.25e-06	8.36e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NUP98—hematologic cancer	6.24e-06	8.35e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.2e-06	8.29e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTAP—hematologic cancer	6.18e-06	8.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ARNTL—hematologic cancer	6.18e-06	8.27e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HDC—hematologic cancer	6.14e-06	8.21e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALOX5—hematologic cancer	6.09e-06	8.14e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ADCY7—hematologic cancer	6.06e-06	8.11e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NCOA3—hematologic cancer	6.06e-06	8.11e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.05e-06	8.09e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NUP214—hematologic cancer	6.02e-06	8.05e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA9—hematologic cancer	6.01e-06	8.04e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ACP5—hematologic cancer	6.01e-06	8.04e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTP1—hematologic cancer	5.96e-06	7.97e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOR2—hematologic cancer	5.94e-06	7.94e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NUP98—hematologic cancer	5.9e-06	7.89e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCG2—hematologic cancer	5.9e-06	7.88e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTR—hematologic cancer	5.9e-06	7.88e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—CREBBP—hematologic cancer	5.86e-06	7.83e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ENO2—hematologic cancer	5.78e-06	7.73e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.77e-06	7.72e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ADCY7—hematologic cancer	5.73e-06	7.66e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NCOA3—hematologic cancer	5.73e-06	7.66e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NUP214—hematologic cancer	5.69e-06	7.6e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—IDH1—hematologic cancer	5.65e-06	7.56e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ABCB1—hematologic cancer	5.64e-06	7.55e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.63e-06	7.52e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CDA—hematologic cancer	5.61e-06	7.51e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTT1—hematologic cancer	5.61e-06	7.5e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCC3—hematologic cancer	5.59e-06	7.48e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTO1—hematologic cancer	5.59e-06	7.48e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TXN—hematologic cancer	5.59e-06	7.48e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCG2—hematologic cancer	5.57e-06	7.45e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTR—hematologic cancer	5.57e-06	7.45e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—FHL2—hematologic cancer	5.51e-06	7.37e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SDC1—hematologic cancer	5.48e-06	7.33e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NCOR1—hematologic cancer	5.48e-06	7.33e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTM1—hematologic cancer	5.48e-06	7.33e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SPHK1—hematologic cancer	5.47e-06	7.32e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ENO2—hematologic cancer	5.46e-06	7.31e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AGRN—hematologic cancer	5.41e-06	7.23e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PC—hematologic cancer	5.4e-06	7.23e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTT1—hematologic cancer	5.3e-06	7.09e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—UGT1A1—hematologic cancer	5.26e-06	7.03e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.22e-06	6.98e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GBA—hematologic cancer	5.22e-06	6.98e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.22e-06	6.98e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SDC1—hematologic cancer	5.18e-06	6.93e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—IDH2—hematologic cancer	5.12e-06	6.85e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HMMR—hematologic cancer	5.12e-06	6.85e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CRABP1—hematologic cancer	5.11e-06	6.84e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC22A1—hematologic cancer	5.11e-06	6.84e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALOX5—hematologic cancer	4.98e-06	6.66e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.95e-06	6.62e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.88e-06	6.53e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—MTHFR—hematologic cancer	4.84e-06	6.48e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.83e-06	6.46e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NUP98—hematologic cancer	4.83e-06	6.45e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ARNTL—hematologic cancer	4.82e-06	6.44e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTAP—hematologic cancer	4.77e-06	6.38e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ACP5—hematologic cancer	4.69e-06	6.27e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA9—hematologic cancer	4.69e-06	6.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ADCY7—hematologic cancer	4.69e-06	6.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOA3—hematologic cancer	4.69e-06	6.27e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.67e-06	6.25e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CD44—hematologic cancer	4.66e-06	6.23e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NQO1—hematologic cancer	4.66e-06	6.23e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NUP214—hematologic cancer	4.65e-06	6.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.63e-06	6.19e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.6e-06	6.16e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.56e-06	6.1e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTR—hematologic cancer	4.56e-06	6.1e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO2—hematologic cancer	4.47e-06	5.98e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYCS—hematologic cancer	4.41e-06	5.9e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—IDH1—hematologic cancer	4.41e-06	5.89e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NQO1—hematologic cancer	4.4e-06	5.89e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CD44—hematologic cancer	4.4e-06	5.89e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.38e-06	5.86e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.36e-06	5.83e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TXN—hematologic cancer	4.36e-06	5.83e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.36e-06	5.83e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.34e-06	5.8e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.31e-06	5.77e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.27e-06	5.71e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.27e-06	5.71e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.26e-06	5.7e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—FHL2—hematologic cancer	4.25e-06	5.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SDC1—hematologic cancer	4.24e-06	5.67e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AGRN—hematologic cancer	4.17e-06	5.58e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYCS—hematologic cancer	4.17e-06	5.57e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	4.14e-06	5.54e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.1e-06	5.48e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CG—hematologic cancer	4.07e-06	5.44e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.05e-06	5.41e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4e-06	5.34e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.98e-06	5.33e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.98e-06	5.33e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—IDH2—hematologic cancer	3.95e-06	5.29e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HMMR—hematologic cancer	3.95e-06	5.29e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.89e-06	5.2e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.88e-06	5.19e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.82e-06	5.11e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CREBBP—hematologic cancer	3.77e-06	5.05e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NUP98—hematologic cancer	3.76e-06	5.03e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.73e-06	4.98e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.72e-06	4.97e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.68e-06	4.92e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—hematologic cancer	3.67e-06	4.91e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.65e-06	4.88e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.65e-06	4.88e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NUP214—hematologic cancer	3.63e-06	4.85e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA9—hematologic cancer	3.62e-06	4.84e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ACP5—hematologic cancer	3.62e-06	4.84e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NQO1—hematologic cancer	3.6e-06	4.82e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CD44—hematologic cancer	3.6e-06	4.82e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.59e-06	4.8e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CD—hematologic cancer	3.58e-06	4.78e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MAPK3—hematologic cancer	3.57e-06	4.78e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.57e-06	4.78e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.57e-06	4.78e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.57e-06	4.77e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.55e-06	4.75e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTR—hematologic cancer	3.55e-06	4.75e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.55e-06	4.75e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALB—hematologic cancer	3.53e-06	4.72e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.53e-06	4.72e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO2—hematologic cancer	3.48e-06	4.66e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCB1—hematologic cancer	3.48e-06	4.65e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—hematologic cancer	3.48e-06	4.65e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYCS—hematologic cancer	3.41e-06	4.56e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—IDH1—hematologic cancer	3.4e-06	4.55e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.39e-06	4.53e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.38e-06	4.52e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3R1—hematologic cancer	3.38e-06	4.52e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NCOR1—hematologic cancer	3.37e-06	4.51e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—hematologic cancer	3.37e-06	4.51e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TXN—hematologic cancer	3.36e-06	4.5e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.36e-06	4.5e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.36e-06	4.5e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.33e-06	4.45e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SDC1—hematologic cancer	3.3e-06	4.42e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.29e-06	4.4e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.16e-06	4.23e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.16e-06	4.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.15e-06	4.22e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CB—hematologic cancer	3.12e-06	4.17e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.11e-06	4.16e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.08e-06	4.11e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.08e-06	4.11e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.05e-06	4.08e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.01e-06	4.02e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	3e-06	4.01e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—hematologic cancer	2.98e-06	3.99e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.98e-06	3.98e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.91e-06	3.89e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NUP98—hematologic cancer	2.9e-06	3.88e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.84e-06	3.8e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.82e-06	3.77e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.82e-06	3.77e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NQO1—hematologic cancer	2.81e-06	3.75e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CD44—hematologic cancer	2.81e-06	3.75e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NUP214—hematologic cancer	2.8e-06	3.74e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.76e-06	3.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.76e-06	3.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.75e-06	3.68e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.74e-06	3.67e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTR—hematologic cancer	2.74e-06	3.67e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—hematologic cancer	2.69e-06	3.6e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ENO2—hematologic cancer	2.69e-06	3.59e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYCS—hematologic cancer	2.66e-06	3.55e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.65e-06	3.55e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.64e-06	3.53e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.63e-06	3.51e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.61e-06	3.49e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—EP300—hematologic cancer	2.57e-06	3.44e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SDC1—hematologic cancer	2.55e-06	3.41e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—hematologic cancer	2.51e-06	3.35e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.46e-06	3.29e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.44e-06	3.26e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—hematologic cancer	2.41e-06	3.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.38e-06	3.18e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.34e-06	3.13e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.33e-06	3.12e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CREBBP—hematologic cancer	2.32e-06	3.11e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALB—hematologic cancer	2.3e-06	3.08e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.27e-06	3.03e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.22e-06	2.96e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.2e-06	2.95e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.2e-06	2.94e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALB—hematologic cancer	2.17e-06	2.91e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NQO1—hematologic cancer	2.17e-06	2.9e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CD44—hematologic cancer	2.17e-06	2.9e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.15e-06	2.88e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.15e-06	2.88e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.15e-06	2.88e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.08e-06	2.78e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.05e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYCS—hematologic cancer	2.05e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.04e-06	2.72e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.03e-06	2.72e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.92e-06	2.57e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.9e-06	2.54e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.9e-06	2.54e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—hematologic cancer	1.9e-06	2.54e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.81e-06	2.42e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.8e-06	2.41e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALB—hematologic cancer	1.78e-06	2.38e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—hematologic cancer	1.76e-06	2.35e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.71e-06	2.29e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.7e-06	2.28e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.68e-06	2.24e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—EP300—hematologic cancer	1.67e-06	2.24e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.66e-06	2.22e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.66e-06	2.22e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—hematologic cancer	1.66e-06	2.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.6e-06	2.14e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—EP300—hematologic cancer	1.58e-06	2.12e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.57e-06	2.1e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—hematologic cancer	1.55e-06	2.08e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.47e-06	1.96e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.4e-06	1.88e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALB—hematologic cancer	1.39e-06	1.85e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—hematologic cancer	1.36e-06	1.82e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.33e-06	1.77e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EP300—hematologic cancer	1.29e-06	1.73e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.24e-06	1.66e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.23e-06	1.65e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.22e-06	1.64e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.17e-06	1.57e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.14e-06	1.53e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.08e-06	1.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALB—hematologic cancer	1.07e-06	1.43e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—hematologic cancer	1.06e-06	1.41e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.02e-06	1.37e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—hematologic cancer	1.01e-06	1.35e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EP300—hematologic cancer	1.01e-06	1.35e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.58e-07	1.28e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—hematologic cancer	9.56e-07	1.28e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.45e-07	1.26e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—hematologic cancer	8.16e-07	1.09e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—hematologic cancer	7.82e-07	1.05e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EP300—hematologic cancer	7.79e-07	1.04e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.46e-07	9.98e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—hematologic cancer	6.1e-07	8.15e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.76e-07	7.7e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—hematologic cancer	4.71e-07	6.29e-06	CbGpPWpGaD
